首页 正文

A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles

{{output}}
Nanoparticles are frequently designed as carriers to mediate the active transport of their cargo to the site of action, thereby serving as effector particles. However, after their in vivo administration, they become quickly recognized by immune cells and are c... ...